A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
Clinical trial NCT06388733 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06388733
- Sponsor
- Ivy Brain Tumor Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-19
- Primary completion
- 2027-12-01
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.